Mosaic raises $47 million to develop AI-guided surgical catheters
Also covered by 1 source
What happened
Mosaic Intelligence Labs, a San Francisco-based company, announced on November 10, 2026, that it has secured $47 million in seed funding. The company is developing AI-driven robotic systems and catheters designed to autonomously navigate blood vessels during endovascular surgeries. Mosaic's technology aims to provide real-time 3D anatomical views and assist surgeons with enhanced navigation and precision. The company was founded by Ileana Pirozzi and Alison Kight Mackanic, who met during their doctoral studies at Stanford.
Key details
- $47 million seed funding raised
- Backers include 8VC, Fundomo, Lingotto Innovation, and Obvious Ventures
- Focus on endovascular procedures using AI-guided robotic catheters
- Technology combines sensors, 3D anatomical reconstruction, and robotic control
- No clinical performance results or patient outcomes reported yet
Why it matters
Hospitals and surgeons performing endovascular procedures could gain access to new tools that improve navigation and precision during minimally invasive surgeries. This technology may reduce reliance on individual operator experience and potentially lower radiation exposure for both patients and medical staff. Companies developing surgical robotics and AI-guided medical devices now face a new competitor with significant early funding and technical ambitions.